|
GHRS
|
GH Research PLC
|
US
|
NASDAQ
|
|
GILD
|
Gilead Sciences, Inc.
|
US
|
NASDAQ
|
|
GLSI
|
Greenwich LifeSciences, Inc.
|
US
|
NASDAQ
|
|
GMDA
|
Gamida Cell Ltd.
|
US
|
NASDAQ
|
|
GNFT
|
GENFIT S.A.
|
US
|
NASDAQ
|
|
GOSS
|
Gossamer Bio, Inc.
|
US
|
NASDAQ
|
|
GRCL
|
Gracell Biotechnologies Inc.
|
US
|
NASDAQ
|
|
GRFS
|
Grifols, S.A.
|
US
|
NASDAQ
|
|
GTBP
|
GT Biopharma, Inc.
|
US
|
NASDAQ
|
|
GTHX
|
G1 Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HAYN
|
Haynes International, Inc.
|
US
|
NASDAQ
|
|
HEPA
|
Hepion Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
HOOK
|
HOOKIPA Pharma Inc.
|
US
|
NASDAQ
|
|
HOWL
|
Werewolf Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IBIO
|
iBio, Inc.
|
US
|
AMEX
|
|
IBRN
|
iShares Neuroscience and Healthcare ETF
|
US
|
AMEX
|
|
ICVX
|
Icosavax, Inc.
|
US
|
NASDAQ
|
|
IFRX
|
InflaRx N.V.
|
US
|
NASDAQ
|
|
IMAB
|
I-Mab
|
US
|
NASDAQ
|